187 related articles for article (PubMed ID: 12047134)
1. Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders.
Douglas VK; Tallman MS; Cripe LD; Peterson LC
Am J Clin Pathol; 2002 Jun; 117(6):844-50. PubMed ID: 12047134
[TBL] [Abstract][Full Text] [Related]
2. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
[TBL] [Abstract][Full Text] [Related]
3. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.
Gonen C; Haznedaroglu IC; Aksu S; Koca E; Göker H; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar S
Platelets; 2005 Feb; 16(1):31-7. PubMed ID: 15763894
[TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human thrombopoietin: clinical experience and in vivo biology.
Vadhan-Raj S
Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
[TBL] [Abstract][Full Text] [Related]
6. [Acute myeloid leukemia with megakaryocytic predominance and malignant megakaryocyte proliferation. Apropos of 3 cases].
Nigro M; Ascari E; Compagnoni A; Menestrina F
Ann Anat Pathol (Paris); 1979; 24(2):171-84. PubMed ID: 294156
[TBL] [Abstract][Full Text] [Related]
7. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes].
Brière J; Kiladjian JJ; Peynaud-Debayle E
C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.
Buss DH; O'Connor ML; Woodruff RD; Richards F; Brockschmidt JK
Arch Pathol Lab Med; 1991 May; 115(5):475-80. PubMed ID: 2021316
[TBL] [Abstract][Full Text] [Related]
9. Effects of thrombopoietin on megakaryocyte colony formation from leukemic cells at diagnosis and from marrow cells after induction chemotherapy for acute leukemias.
Liang DC; Shih LY; Kuo MC; Chen SH; Liu HC; Shimosaka A
Ann Hematol; 1998; 77(1-2):33-9. PubMed ID: 9760150
[TBL] [Abstract][Full Text] [Related]
10. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
[TBL] [Abstract][Full Text] [Related]
11. [Clinical use of recombinant human thrombopoietin. Status and perspectives].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2001 May; 163(19):2659-62. PubMed ID: 11360368
[TBL] [Abstract][Full Text] [Related]
12. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease.
Hirayama Y; Sakamaki S; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Kuroda H; Kusakabe T; Akiyama T; Kato J; Niitsu Y
Am J Hematol; 2003 Aug; 73(4):285-9. PubMed ID: 12879435
[TBL] [Abstract][Full Text] [Related]
14. [The relativity study of thrombopoietin and chronic idiopathic thrombocytopenic purpura].
Liao X; Wang Y; Deng C
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):473-5. PubMed ID: 11758228
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases.
Panteli KE; Hatzimichael EC; Bouranta PK; Katsaraki A; Seferiadis K; Stebbing J; Bourantas KL
Br J Haematol; 2005 Sep; 130(5):709-15. PubMed ID: 16115126
[TBL] [Abstract][Full Text] [Related]
17. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
18. [Bone-marrow biopsy in chronic myeloid leukemia. Value of the initial examination].
Devred C; Bentata J; Diebold J; Bernadou A; Bilski-Pasquier G
Sem Hop; 1977 Jan; 53(2):119-24. PubMed ID: 189424
[TBL] [Abstract][Full Text] [Related]
19. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.
Chen YC; Chou JM; Letendre L; Li CY
Am J Hematol; 2005 Aug; 79(4):329-31. PubMed ID: 16044436
[TBL] [Abstract][Full Text] [Related]
20. Use of thrombopoietic growth factors in acute leukemia.
Kaushansky K
Leukemia; 2000 Mar; 14(3):505-8. PubMed ID: 10720151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
